報價延遲最少15分鐘:2025/01/21 08:38 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.7243 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.71/-0.94
|
|
企業價值
70.94M
|
| 資產負債 |
|
每股賬面淨值
1.59
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
6.21M
|
|
每股收益
0.21
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:38 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNetand a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries. |